OTCMKTS:LTUS Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis → Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad) Free LTUS Stock Alerts $0.0070 0.00 (0.00%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$0.0070▼$0.007050-Day Range$0.0035▼$0.007552-Week Range$0.0035▼$0.0120VolumeN/AAverage Volume159 shsMarket Capitalization$18.86 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Lotus Pharmaceuticals alerts: Email Address Ad Timothy SykesUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo, or CNBC.See Tim’s instructions to make this remarkably simple trade right here About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS)Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.Read More LTUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LTUS Stock News HeadlinesApril 18, 2024 | yahoo.comLotus’s New Electric SUV Is Coming This YearApril 16, 2024 | msn.comResearchers explore medicinal potential of lotus benzylisoquinoline alkaloidsApril 20, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 14, 2024 | au.news.yahoo.comModi promises India jobs, infrastructure if re-electedApril 14, 2024 | msn.comIndia's Modi promises jobs, infrastructure if BJP wins third termApril 12, 2024 | msn.comIs It a Miracle Drug or the Latest Showroom Sensation?April 12, 2024 | ca.finance.yahoo.comLotus Ventures Inc. (J.CN)April 10, 2024 | msn.comAnd Just Like That, Lotus Is an EV MakerApril 20, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 8, 2024 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar DepressionApril 6, 2024 | msn.comLong-standing vegan restaurant Blossoming Lotus closes after two decades in PortlandApril 4, 2024 | msn.comFentanyl kills thousands of Americans. Could plugging a gap in U.S. intelligence save lives?April 3, 2024 | finance.yahoo.comQ4 2023 NRX Pharmaceuticals Inc Earnings CallApril 3, 2024 | msn.comThis Swiss Car Company Built A Scuba-Diving Lotus Elise EVApril 2, 2024 | msn.comSteel Lotus Fitness to raise money for Harrisburg police K9March 29, 2024 | msn.com‘1923’ Breakout Brandon Sklenar To Co-Star Opposite Meghann Fahy In Christopher Landon’s ‘Drop’ From Platinum Dunes And BlumhouseMarch 24, 2024 | msn.com‘The White Lotus’ Thailand is next. These hotels do it on a budget.March 11, 2024 | msn.comLotus’s New Electric Flagship: The Emeya Hyper GT SedanMarch 8, 2024 | msn.comLotus Emira Finally Cleared For Sale In U.S. After Three YearsFebruary 26, 2024 | msn.comA former resident of The World cruise ship spent 6 years onboard, says it's not unlike 'The White Lotus'February 26, 2024 | msn.comEV maker Lotus Technology begins second week of trading after SPAC debutFebruary 26, 2024 | reuters.comChina securities regulator says penalties will be severe in market crackdownFebruary 19, 2024 | msn.comInternational Autism Conference scheduled for 27-30 April in Abu DhabiFebruary 19, 2024 | msn.comNRx Pharma Secures $5M Advance in Milestone Payment for Bipolar Depression DrugFebruary 18, 2024 | forbes.comThai Billionaire Dhanin To Merge Retail Businesses In $215 Million DealFebruary 15, 2024 | yahoo.comEverything to Know About 'The White Lotus' Season 3February 13, 2024 | msn.comLotus Isn’t Opposed to the Idea of Building a Sports Car That Can Drive ItselfSee More Headlines Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:LTUS CUSIPN/A CIKN/A Webwww.lotuspharma.com Phone(941) 267-9684Fax86-10-6389-9867Employees233Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,694,510,000Free FloatN/AMarket Cap$18.86 million OptionableNot Optionable Beta-0.42 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesDr. Zhong Yi Liu (Age 63)Founder, Chairman, Chief Executive Officer and President Comp: $180kMs. Yan Zeng (Age 55)Chief Financial Officer and Principal Accounting Officer Dr. Xing Shen (Age 53)Vice President of Corporate Development Key CompetitorsRenovoRxNASDAQ:RNXTChina Health IndustriesOTCMKTS:CHHEKALA BIONASDAQ:KALAGalectoNASDAQ:GLTOFSD PharmaNASDAQ:HUGEView All Competitors LTUS Stock Analysis - Frequently Asked Questions How have LTUS shares performed in 2024? Lotus Pharmaceuticals' stock was trading at $0.0043 at the start of the year. Since then, LTUS shares have increased by 62.8% and is now trading at $0.0070. View the best growth stocks for 2024 here. How do I buy shares of Lotus Pharmaceuticals? Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LTUS) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesTiny Biotech Stock Wins $75 Billion PatentBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.